Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,158.50    19.50 (1.71%)
Bid:
1,158.50
Ask:
1,159.00
Spread: 0.50 (0.043%)
Market Cap: £9.83b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

9 May 2019 15:14

RNS Number : 5624Y
Smith & Nephew Plc
09 May 2019
 

 

SMITH & NEPHEW PLC

 

9 May 2019

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Graham Baker

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Smith & Nephew plc

b)

LEI

213800ZTMDN8S67S1H61

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Smith & Nephew plc ordinary shares of USD 0.20 each

 

ISIN: GB0009223206

b)

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2018 final dividend payment on 8 May 2019.

c)

Price(s) and volume(s)

Price(s)

£16.2523

Volume(s)

26

d)

Aggregated information

- Aggregated volume

- Price

Single Transaction

N/A

N/A

e)

Date of the transaction

2019 - 05 - 09

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Anne-Marie Baker

2

Reason for the notification

a)

Position/status

PCA of Graham Baker, Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Smith & Nephew plc

b)

LEI

213800ZTMDN8S67S1H61

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Smith & Nephew plc ordinary shares of USD 0.20 each

 

ISIN: GB0009223206

b)

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2018 final dividend payment on 8 May 2019.

c)

Price(s) and volume(s)

Price(s)

£16.2527

£16.1335

Volume(s)

15

63

d)

Aggregated information

- Aggregated volume

- Price

 

78

£16.1564

e)

Date of the transaction

2019 - 05 - 09

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

Susan Swabey

Company Secretary

Smith & Nephew plc

 

Tel: 01923 477216

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFLSEFIAIIA
Date   Source Headline
15th Feb 20195:32 pmRNSTransaction in Own Shares
14th Feb 20195:37 pmRNSTransaction in Own Shares
14th Feb 20198:14 amRNSDirector Declaration
13th Feb 20195:17 pmRNSTransaction in Own Shares
12th Feb 20195:20 pmRNSTransaction in Own Shares
11th Feb 20195:41 pmRNSTransaction in Own Shares
8th Feb 20191:59 pmRNSTransaction in Own Shares
8th Feb 20199:20 amRNSDirector/PDMR Shareholding
8th Feb 20199:17 amRNSDirectorate Change
7th Feb 20197:00 amRNSFinal Results
1st Feb 20192:04 pmRNSBlock listing Interim Review
1st Feb 201912:06 pmRNSTotal Voting Rights
22nd Jan 20192:38 pmRNSSmith & Nephew acquires Ceterix Orthopaedics
16th Jan 20195:19 pmRNSDirector/PDMR Shareholding
11th Jan 20199:00 amRNSNotice of Results
7th Jan 20197:00 amRNSSmith & Nephew to present today at JP Morgan
4th Jan 20195:32 pmRNSSmith & Nephew at JP Morgan Healthcare Conference
2nd Jan 201911:19 amRNSTotal Voting Rights
18th Dec 20184:30 pmRNSAcquisition
7th Dec 201810:26 amRNSDirector/PDMR Shareholding
4th Dec 20184:20 pmRNSDirector/PDMR Shareholding
4th Dec 20184:18 pmRNSDirector/PDMR Shareholding
3rd Dec 201812:00 pmRNSTotal Voting Rights
26th Nov 20183:07 pmRNSTransaction in Own Shares
22nd Nov 201811:57 amRNSTransaction in Own Shares
21st Nov 20185:31 pmRNSTransaction in Own Shares
20th Nov 20185:18 pmRNSTransaction in Own Shares
19th Nov 20185:49 pmRNSTransaction in Own Shares
16th Nov 20182:19 pmRNSDirector/PDMR Shareholding
16th Nov 201810:21 amRNSDirector/PDMR Shareholding
16th Nov 20188:59 amRNSTransaction in Own Shares
14th Nov 20184:46 pmRNSDirector/PDMR Shareholding
12th Nov 20183:46 pmRNSDirector/PDMR Shareholding
9th Nov 20184:26 pmRNSDirector/PDMR Shareholding
6th Nov 20188:55 amRNSDirector/PDMR Shareholding
5th Nov 20188:24 amRNSDirector/PDMR Shareholding
1st Nov 20184:26 pmRNSDirector/PDMR Shareholding
1st Nov 20183:20 pmRNSDirector/PDMR Shareholding
1st Nov 20183:00 pmRNSTotal Voting Rights
1st Nov 20187:00 amRNSTrading Statement
31st Oct 20184:00 pmRNSDirector/PDMR Shareholding
18th Oct 20183:54 pmRNSDividend Declaration
17th Oct 20187:00 amRNSNotice of Results
5th Oct 20184:36 pmRNSDirector/PDMR Shareholding
1st Oct 20181:29 pmRNSTotal Voting Rights
1st Oct 20187:00 amRNSNotice of Results
19th Sep 20188:48 amRNSDirector/PDMR Shareholding
3rd Sep 20181:23 pmRNSTotal Voting Rights
23rd Aug 20184:42 pmRNSDirector/PDMR Shareholding
16th Aug 20182:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.